Cohort has announced a new export contract for MASS as well as a minor delay to completing the EID acquisition in Portugal due to process issues. The latter may lead to some modest trade-off between current-year contribution and net assets acquired, but is essentially a timing issue. The additional work for MASS underpins current-year prospects, which should further support sentiment at the half year. The share price has continued to perform well, edging up to our current fair value of 395p.<
14 Oct 2015
aMASSing contracts
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
aMASSing contracts
Cohort has announced a new export contract for MASS as well as a minor delay to completing the EID acquisition in Portugal due to process issues. The latter may lead to some modest trade-off between current-year contribution and net assets acquired, but is essentially a timing issue. The additional work for MASS underpins current-year prospects, which should further support sentiment at the half year. The share price has continued to perform well, edging up to our current fair value of 395p.<